The absorption of anabolic agents from pellets implanted at the base of the ear in sheep.
Twenty wether sheep were allocated to seven groups and received implants near the base of one ear with pellets containing: for group 1, (OE) 20 mg oestradiol-17 beta alone; for group 2, (TBA/OE) 20 mg oestradiol-17 beta intimately mixed with 140 mg trenbolone acetate; for group 3, (T/OE) 20 mg oestradiol-17 beta mixed with 200 mg testosterone; for group 4, (P/OE) 20 mg oestradiol-17 beta mixed with 200 mg progesterone; for group 5, (TBA/OE2) 20 mg oestradiol-17 beta in one ear and 140 mg trenbolone in the other ear; for group 6, (TBA/OE1) 20 mg oestradiol-17 beta and 140 mg trenbolone as separate pellets in one ear; group 7 sheep received implants of carrier material and served as controls. The concentrations of steroids were measured in plasma samples collected from both jugular veins during the 16-week period after implantation. The absorption of oestradiol-17 beta was slower and more sustained from the pellets in which it was mixed with other steroids (groups 2, 3 and 4) than from the pellets containing oestradiol-17 beta alone (groups 1, 5 and 6). The concentration of each steroid in plasma was higher in the jugular vein ipsilateral to the implant than in the vein on the opposite side. The difference between the concentrations in the two veins was used to calculate the biological half-lives of the steroids; for oestradiol-17 beta and trenbolone the mean values ranged from 1.8 to 6.8 min and from 3 to 4 min, respectively, and for testosterone and progesterone the mean values were 4.7 and 3.5 min, respectively.
D000042:Absorption; D045930:Anabolic Agents / Q000008:administration & dosage*; D000818:Animals; D004338:Drug Combinations; D004343:Drug Implants; D004958:Estradiol / Q000008:administration & dosage* / Q000378:metabolism; D004963:Estrenes / Q000008:administration & dosage*; D005260:Female; D008297:Male; D011374:Progesterone / Q000008:administration & dosage* / Q000378:metabolism; D012756:Sheep / Q000378:metabolism*; D013739:Testosterone / Q000008:administration & dosage* / Q000378:metabolism; D013997:Time Factors; D014018:Tissue Distribution; D014204:Trenbolone Acetate / Q000008:administration & dosage* / Q000031:analogs & derivatives / Q000378:metabolism
D045930:Anabolic Agents; D004338:Drug Combinations; D004343:Drug Implants; D004963:Estrenes; D013739:Testosterone; D011374:Progesterone; D004958:Estradiol; D014204:Trenbolone Acetate